Highlights Charmacy Pharmaceutical Co., Ltd.

Equities

2289

CNE1000023D6

Market Closed - Hong Kong S.E. Other stock markets 09:08:17 17/05/2024 BST			5-day change	1st Jan Change
14.4 ^HKD	+7.78%		+3.75%	+11.11%

04-01	Charmacy Pharmaceutical 2023 Profit Declines on Lower Asset Disposal Gains	MT
03-28	Charmacy Pharmaceutical Co., Ltd. Proposes Final Dividend for the Year Ended 31 December 2023, Payable on 10 July 2024	CI

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Charmacy Pharmaceutical 2023 Profit Declines on Lower Asset Disposal Gains	04-01	MT
Charmacy Pharmaceutical Co., Ltd. Proposes Final Dividend for the Year Ended 31 December 2023, Payable on 10 July 2024	03-28	CI
Charmacy Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	03-28	CI
Charmacy Pharmaceutical’s Profit to Drop by 45% in 2023	03-18	MT
Charmacy Pharmaceutical Meets Minimum Public Float Norms	04/09/23	MT
Charmacy Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	27/08/23	CI
Charmacy Pharmaceutical Co., Ltd. Approves Final Dividend for the Year Ended 31 December 2022, Payable on 31 July 2023	05/06/23	CI
Charmacy Pharmaceutical Co., Ltd. Announces Ordinary Final Dividend for the Year Ended 31 December 2022, Payable on July 31, 2023	25/05/23	CI
Charmacy Pharmaceutical Co., Ltd. Recommends Ordinary Final Dividend for the Year Ended 31 December 2022, Payable on 20 July 2023	31/03/23	CI
Charmacy Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	31/03/23	CI
Jiangxi Jiangzhong Pharmaceutical Commercial Operation Co., Ltd. completed the acquisition of 32.12963% stake in Charmacy Pharmaceutical Co., Ltd. from a group of shareholders.	09/02/23	CI
Jiangxi Jiangzhong Pharmaceutical Commercial Operation Co., Ltd. completed the acquisition of 9% of stake in Charmacy Pharmaceutical Co., Ltd. from Yao Chuanglong.	16/01/23	CI
Jiangxi Jiangzhong Pharmaceutical Commercial Operation Co., Ltd. made an offer to acquire additional 32.12963% stake in Charmacy Pharmaceutical Co., Ltd. from a group of shareholders for approximately HKD 250 million.	16/01/23	CI
Charmacy Pharmaceutical Forecasts Increase in January-November Net Profit	21/12/22	MT
Charmacy Pharmaceutical Co., Ltd. Provides Financial Guidance for the 11 Months Ended 30 November 2022	20/12/22	CI
Jiangxi Jiangzhong Pharmaceutical Commercial Operation Co., Ltd. agreed to acquire 9% of stake in Charmacy Pharmaceutical Co., Ltd. from Yao Chuanglong for HKD 70.9 million.	27/09/22	CI
Charmacy Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022	31/08/22	CI
Charmacy Pharmaceutical Approves Re-Appointment of Shinewing Certified Public Accountants as the Auditors	06/06/22	CI
Charmacy Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021	31/03/22	CI
Charmacy Pharmaceutical Co., Ltd. Provides Earnings Guidance for the Ended 31 December 2021	28/02/22	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Charmacy Pharmaceutical Co., Ltd.

Equities

2289

CNE1000023D6

Highlights

Filters